erlotinib hydrochloride has been researched along with thymidine in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (thymidine) | Trials (thymidine) | Recent Studies (post-2010) (thymidine) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 33,410 | 241 | 1,117 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | thymidine (IC50) |
|---|---|---|---|
| Thymidine kinase | Macacine alphaherpesvirus 1 | 4.1 | |
| Thymidine kinase, cytosolic | Homo sapiens (human) | 0.614 | |
| Thymidine kinase | Human alphaherpesvirus 1 strain SC16 | 1 | |
| Sterol O-acyltransferase 1 | Cricetulus griseus (Chinese hamster) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amler, LC; Charu, V; Fine, BM; Gitlitz, BJ; Hicks, RJ; Hughes, BG; Macfarlane, D; Mileshkin, L; Mitchell, PL; Pirzkall, A; Solomon, B; Yu, W | 1 |
1 trial(s) available for erlotinib hydrochloride and thymidine
| Article | Year |
|---|---|
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Survival Analysis; Thymidine | 2011 |